Abstract: A piston discharge structure for a plasma cloud excitation engine is provided. The piston discharge structure includes a movement electrode, a distributed multi-cavity combustion chamber, a fixed electrode, and a variable interval discharge region. The movement electrode is provided at a top portion of a piston and includes a first combination shape and a first movement electrode structure, the distributed multi-cavity combustion chamber is provided at the top portion of the piston, the fixed electrode is provided at a top portion of a cylinder block or a bottom portion of a cylinder head and including a second combination shape and a second structure, and the variable interval discharge region is defined by the movement electrode and the fixed electrode.

Abstract: A detection apparatus to extract features from an image; determine the number of candidate regions of the object in the image based on the extracted features, wherein the determined number of the candidate regions is decided by a position and shape of the candidate regions; and to detect the object from the image based on at least the extracted features and the determined number, position and shape of the candidate regions.

Abstract: The invention provides compounds that are inhibitors or covalent modifiers of succinate dehydrogenase subunit B (SDHB) and/or inhibitors of apoptosis, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.

Abstract: Provided are piperazine cyclic urea compounds that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), pharmaceutically acceptable salts, hydrates and stereoisomers thereof. Provided are also pharmaceutical compositions, methods of making, and methods of use which include treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Abstract: The present disclosure provides compounds including piperazine heterocyclic amide urea compounds that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Abstract: A series of new macrocycles and cage-like molecules are obtained in a high yield from a bis-(2,4-dialkoxyphenyl)arene (naphthalene, anthracene, pyrene, porphyrin, etc.) or a tris-(2,4-dialkoxyphenyl)arene (benzene, sym-tribenzobenzene) and paraformaldehyde under the catalysis of a Lewis acid. In addition, perhydroxybiphenylarenes (tetrabiphenyl trimer, naphthalene dimer, etc.) can be obtained by means of demethylation, and a variety of water-soluble derivatives can be obtained by further modification, with same exhibiting a good bond ability for guest molecules (purpurine, etc.). Moreover, the functional group introduced into the backbone enables the macrocycle to have excellent adsorption and separation capabilities and a photophysical property.

Abstract: The invention provides compounds that inhibit human MLKL, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.

Abstract: A display module and a method for driving the same, a display apparatus, and a vehicle are provided. The display module includes a backlight component, and a display component and a light-adjusting component that are located at a side of the backlight component facing toward a light-emitting direction of the display module. The backlight component includes a first light guide structure and a light regulating structure. The light-adjusting component includes first and second electrodes, and a first liquid crystal. The display module has a sharing mode and an anti-peeping mode. In the sharing mode, the first electrode and the second electrode are not energized, and the first liquid crystal is in a wide viewing angle state. In the anti-peeping mode, the first electrode and the second electrode drive the first liquid crystal to be in a narrow viewing angle state.

Abstract: Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Abstract: A display module and a method for driving the same, a display apparatus, and a vehicle are provided. The display module includes a backlight component, and a display component and a light-adjusting component that are located at a side of the backlight component facing toward a light-emitting direction of the display module. The backlight component includes a first light guide structure and a light regulating structure. The light-adjusting component includes first and second electrodes, and a first liquid crystal. The display module has a sharing mode and an anti-peeping mode. In the sharing mode, the first electrode and the second electrode are not energized, and the first liquid crystal is in a wide viewing angle state. In the anti-peeping mode, the first electrode and the second electrode drive the first liquid crystal to be in a narrow viewing angle state.

Abstract: One or more processors may be configured to determine one or more prospective routes of an ego vehicle being at least partially controlled by a human driver; receive first sensor data, representing one or more attributes of a second vehicle; determine a danger probability of the one or more prospective routes of the first vehicle using the at least the one or more attributes of the second vehicle from the first sensor data; and if each of the one or more prospective routes of the first vehicle has a danger probability outside of a predetermined range, send a signal representing a safety intervention. Whenever a safety intervention signal is sent, the one or more processors may be configured to increment or decrement a counter.

Abstract: The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Abstract: Embodiments of the present disclosure relate to a method and apparatus for generating information. The method may include: acquiring at least one to-be-processed service and at least one piece of relationship information, the relationship information being used to represent an execution order between two to-be-processed services in the at least one to-be-processed service; constructing a directed graph with a to-be-processed service in the at least one to-be-processed service as a point and with a piece of relationship information in the at least one piece of relationship information as a directed edge; and generating execution order information of the to-be-processed service in the at least one to-be-processed service according to the directed graph.

Abstract: Embodiments of the present disclosure provide devices, techniques, and configurations for network interface controllers (NICs) that log write packets received from a network in non-volatile random access memory (NVRAM). In one embodiment, a NIC includes a network interface to couple a host of the NIC to a network, a NVRAM, and a controller coupled with the network interface and the NVRAM, where the controller is to log write packets received at the network interface from the network in the NVRAM. Other embodiments may be described and/or claimed.

Abstract: Provided are a display device and a preparation method thereof. The display device includes a display panel and a first antireflection structure and a second antireflection structure successively stacked on a side of a display functional layer facing away from a driving substrate, where the display panel includes the driving substrate and the display functional layer. The first antireflection structure includes a first graded-index layer, a conductive layer and a second graded-index layer which are successively stacked; the first graded-index layer includes at least two first sublayers, and the second graded-index layer includes at least two second sublayers. The second antireflection structure includes a third graded-index layer, a first dielectric layer and a fourth graded-index graded layer which are successively stacked; the third graded-index layer includes at least one third sublayer, and the fourth graded-index layer includes at least two fourth sublayers.

Abstract: A safety system (200) for a vehicle (100) is provided. The safety system (200) may include one or more processors (102). The one or more processors (102) may be configured to control a vehicle (100) to operate in accordance with the predefined stored driving model parameters, to detect vehicle operation data during the operation of the vehicle (100), to determine whether to change predefined driving model parameters based on the detected vehicle operation data and the driving model parameters, to change the driving model parameters to changed driving model parameters, and to control the vehicle (100) to operate in accordance with the changed driving model parameters.

Abstract: It relates to methods of treating prostatitis comprising administering to a male in need thereof a necroptosis inhibitor, including inhibitors of RIP1, RIP3 or MLKL. It also relates to pharmaceutical composition comprising a necroptosis inhibitor and a second different drug for treating prostatitis.

Abstract: A display panel and a display device, where the display panel includes a substrate, an insulation layer, a conductive layer, a first planarization layer, an OLED layer and an encapsulation layer which are stacked in sequence, where a plurality of first grooves are formed in the conductive layer, and the first planarization layer fills the first grooves and covers the conductive layer; the display panel further includes a compensation layer, where a plurality of second grooves are formed in the compensation layer, and projection of the compensation layer on the substrate at least overlaps with projection of part of the first grooves on the substrate.

Abstract: An array substrate and a display panel, which relate to the technical field of flexible displays and are used for solving the problem of the Newton's ring phenomenon due to unequal spacing between transparent layers affects the display effect of the display panel. The array substrate or a display panel include at least two transparent layers stacked in sequence, and a light adjusting layer arranged between at least two adjacent transparent layers, where a product of a refractive index of the light adjusting layer and a thickness of the light adjusting layer is greater than one half of a preset wave train length.